Skip to content

BIOCARE

Active Private limited companyfounded 2017active for 9 yearsRue de la Berwinne 17, 4450 JuprelleKBO/BCE: BE 0669.941.683

Lifetime

8 annual accounts with figures on one time axis
peak of €281,914 in 2024
€281,914▲ 22.7%
lowest -€1,104 in 2024
-€1,104▼ €63,970
peak of €390,775 in 2020
€279,068▼ 0.4%
€1.8m▲ 1.7%
peak of 2.2 FTE in 2020
-not published
Board3 names since 2017
1 director
Documentsfilings and deeds
08-05-2026281 days late
2024micro format
Gross margin from €229,812 to €281,914Loss of €1,104Cash from €2,048 to €12,515

Key points

from the 2024 annual accounts

Result

-€1,104 -€1,104
€62,9002023-€1,1002024

From profit to loss in 2024, after a profit of €62,866 in 2023.

Debts

€1.8m 87% of the balance sheet
Financial debts 86%Suppliers 6%Taxes and wages 2%Other 6%

Of this, €440,688 falls due within a year.

Investments

€943 0.0 times depreciation
2021202220232024

Green is investment, beige is depreciation.

Staff

2.8 FTE from 5.4 in 2022

Between 2022 and 2024, the number of full-time equivalents fell by 48%.

Filings

8 annual accounts 111 days past the deadline
AprilJune31 JulyOctober2020

2025 accounts not filed: deadline was 31-07-2026.

Position in the sector

€279,068

More equity than 90% of companies in chemicals. The sector median is €23,617, over 167 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,548 companies had the same profile as BIOCARE has now. Each dot stands for 4 companies, two years later.

91.3%
were still trading
3.9%
stopped another way
4.3%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 10 to 30%
  • a small loss

Another 0.5% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,548 companies, not a prediction for BIOCARE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
  • 95 sharesdeed of 06-01-2022
  • 5 sharesdeed of 06-01-2022
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0669941683
appointed as director Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 06-02-2025 · Gazette deed
Registered office moved within Lantin The registered office moved from Rue de la Berwinne, 12 4450 LANTIN to rue de la Berwinne, 17 à 4450 LANTIN · holds 95 shares · holds 5 shares · General meeting of 30-09-2021 · Gazette deed
First establishment Rue de la Berwinne 12, Juprelle
All 17 events

Comparable companies

same main activity, similar in size and age
Company
BIOCARE Juprelle €2.1m €0.3m 13.1% -
NATURALIS-COSMETICS Diepenbeek €2.3m €0.3m 66.7% 4.2
Minasolve Solutions Mont-Saint-Guibert €2.2m €1.2m 80.4% 9.3
CÎME Brussels €1.0m €0.2m 40.9% 2
CEREPHARMA Ath €1.5m €0.6m 61.2% 6.3
CosmXpert Brussels €1.5m €0.6m -10.1% 4.3
CSS COSMETICS Sint-Truiden €2.0m €0.3m 71.9% 1

These companies have the same main activity as BIOCARE: manufacture of chemicals and chemical products (NACE 20420). They are comparable in size and age: total assets between €1m and €2.3m, founded between 2008 and 2019.

Official details

Source: KBO
Status
Active since 24-01-2017Normal situation
Activity
Manufacture of chemicals and chemical productsNACE 20420
Establishment unit
2.260.990.4204450 Juprelle, since 07-02-2017
Financial year end
31 December
Peppol
Reachable since 01-09-2026
Company details

Annual accounts 2024

≈ €570,000estimated
€2.1m▲ 1.4%
Employeeson 31-12-2024
3▼ 25.0%
Filing
Filed on 08-05-2026
Financials

Insights on BIOCARE

BIOCARE files the micro format. That format states no turnover. The gross margin rose from €84,921 in 2017 to €281,914 in 2024.

The balance sheet grew most from 2022 to 2024 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BIOCARE

What is the company number of BIOCARE?
The company number of BIOCARE is 0669.941.683. The VAT number is the same number with BE in front: BE 0669.941.683.
Where is BIOCARE based?
The registered office is at Rue de la Berwinne 17, 4450 Juprelle.Company details
What does BIOCARE do?
According to the KBO register, the main activity is manufacture of chemicals and chemical products (NACE 20420).
What is the legal form of BIOCARE?
BIOCARE is a private limited company (BV).
When was BIOCARE founded?
BIOCARE was founded on 24-01-2017.
Is BIOCARE still active?
Yes, BIOCARE is an active enterprise in the KBO register.
How many employees does BIOCARE have?
BIOCARE had an average of 2.8 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
What is the turnover of BIOCARE?
The turnover in financial year 2024 is about €570,000. This figure is estimated from the gross margin of €281,914 and 1,018 comparable companies of the same size. It probably lies between €390,000 and €830,000. It is a rough estimate.
Is BIOCARE profitable?
In financial year 2024, BIOCARE made a loss of €1,104.
Where can I find the annual accounts of BIOCARE?
BIOCARE filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2024.
When are the next annual accounts of BIOCARE due?
BIOCARE had to file the annual accounts for financial year 2025 by 31-07-2026. On 19-11-2026 they are not filed yet, 111 days past the deadline.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.